advertisement

---

Your Special Attention For IGR 13-2

Auto-immunity and glaucoma

F.H. Grus and O.W. Gramlich
Klinische Monatsblätter fur Augenheilkunde 2011; 228: 439-445

Abstract no. 869

---

The causal connection.

---

Driving simulation as a performance-based test of visual impairment in glaucoma

F.A. Medeiros, R.N. Weinreb, E. Boer and P.N. Rosen
Journal of Glaucoma 2011

Abstract no. 1082

---

Information acquired by technologically advanced tests have not resulted in a clear understanding of vision-related quality of life. Driving simulators may provide insight into the different mechanisms like driving safety and performance.

---

Glaucoma

H.A. Quigley
The Lancet 2011; 377: 1367-1377

Abstract no. 1089

---

Glaucoma: 60 million people worldwide affected. What do we know?

---

Loss of chance: A new kind of damage to ophthalmologic patients from Europe to Italy

A. Molinelli, A. Bonsignore, M. Capecchi and G. Calabria
European Journal of Ophthalmology 2011; 21: 310-314

Abstract no. 1083

---

Does Europe need a new legislature on the causal link between iatrogenic illicit behavior and damage to the patient?

---

Management of blebitis in the United Kingdom: A survey

P.J.T. Chiam, K. Arashvand, A. Shaikh and B. James
British Journal of Ophthalmology 2011

Abstract no. 1042

---

There is no uniform treatment strategy for our patients with blebitis.

---

Novel drug delivery systems for glaucoma

E. Lavik, M.H. Kuehn and Y.H. Kwon
Eye 2011; 25: 578-586

Abstract no. 960

---

The benefits and limitations of current and potentially new systems for delivery and application of drugs.

---

Pregnancy and glaucoma

M.R. Razeghinejad, T.Y. Tania Tai, S.J. Fudemberg and L.J. Katz
Survey of Ophthalmology 2011

Abstract no. 882

---

A special therapeutic approach is needed for the treatment of glaucoma in pregnancy.

---

Primary open-angle glaucoma genes

J.H. Fingert
Eye 2011; 25: 587-595

Abstract no. 554

---

Different approaches to study glaucoma genetics provide different answers on pathogenesis.

---

Stem cell therapy for glaucoma: Possibilities and practicalities

T.V. Johnson, N.D. Bull and K.R. Martin
Expert Review of Ophthalmology 2011; 6: 165-174

Abstract no. 544

---

A fairy tale: how far away is stem cell therapy for glaucoma?

---

Update on aqueous shunts

S.J. Gedde, R.K. Parrish II, D.L. Budenz and D.K. Heuer
Experimental Eye Research 2011;

Abstract no. 1012

---

Aqueous shunt or trabeculectomy? That's the question.

---

Editorials that are worth reading:

Ocular hypertension and normal-tension glaucoma: time for banishment and burial

A. Sommer.
Archives of Ophthalmology 2011; 129: 785-787.

The tube versus trabeculectomy study: why its findings may not change clinical practice?

J. Caprioli
Clinical and Experimental Ophthalmology 2011; 39: 95-96

Can we screen for angle closure?

L.M. Sakata and T. Aung
Amercan Journal of Ophthalmology 2011 Apr;151(4):567-8.

Broadening our focus in the search for cell transplantation-based glaucoma therapies

T.V. Johnson and K.R. Martin
Eye (Lond) 2011; 25: 541-543.

Pediatric glaucoma: Baby steps to improved control

N. Sachdev and S. Carden
Clinical and Experimental Ophthalmology 2011; 39: 191-192.

Monitoring intraocular pressure for 24 h

J.H. Liu and R.N. Weinreb
British Journal of Ophthalmology 2011; 95: 599-600. Epub 2011 Feb 17.